FindTrial
Sign In

A Study to Compare the usefulness of two Blood Products in the Surgery of Ear Drum Perforation

A study to compare the outcomes of Type 1 Tympanoplasty with the Use of Platelet Rich Fibrin versus Platelet Rich Plasma - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070204
Enrollment
40
Registered
2024-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H729- Unspecified perforation of tympanic membrane Health Condition 2: H729- Unspecified perforation of tympanic membrane

Interventions

Intervention1: Platelet Rich Fibrin: Patients Undergoing Type 1 Tympanoplasty With The Use Of Platelet Rich Fibrin Which Will Be Done For 1 Year Control Intervention1: Platelet Rich Plasma: Patients U

Sponsors

Dr Vanshika Singhal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients admitted and willing for the procedure Patients with Chronic Otitis Media Tubotympanic Type Patients with conductive hearing loss less than 40db Dry ear for atleast 6 weeks

Exclusion criteria

Exclusion criteria: Patients with Uncontrolled DM SHTN Bleeding Diathesis CAD Patients with mixed hearing loss

Design outcomes

Primary

MeasureTime frame
To compare the graft uptake in type 1 tympanoplasty using Temporalis Fascia with PRF and with the application of PRPTimepoint: Once weekly for one month Fortnightly for three months Six months ELVE MONTHS—

Secondary

MeasureTime frame
To compare the hearing outcomes in type 1 tympanoplasty using Temporalis Fascia with PRF & with the application of PRP To assess the complications of applications of PRF & PRP in type 1 tympanoplasty Timepoint: Once weekly for one month Fortnightly for three months Six months—

Countries

India

Contacts

Public ContactDr Saurabh Saini

Varun Arjun Medical College and Rohilkhand Hospital

santhanakrishnan2709@gmail.com8940132448

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026